Additionally, increased CISD2 expression was observed in drug-resistant DLBCL cell lines, and knocking down CISD2 enhances ferroptosis, thereby increasing sensitivity to DOX. This evidence concerns the gene CISD2 and diffuse large B-cell lymphoma.